Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation

Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps. The European Medicines Agency's Committee for Medicinal Produc...
Streetwise Reports | September 24, 2019 |

Why There is Still a Dire Need for COVID-19 Testing

(Click image to play video) While the tide has turned in many countries in battle against the COVID-19, the global pandemic is far from over in countries like India, for example. Thus, the need for quick, reliable COVID at-home testing is still existential. T...
Dave Jackson | June 7, 2021 |

“Empowering” a New Revolution in Mind, Body and Health Care

When Stockhouse first met up with Empower Clinics Inc . ( CSE.CBDT , OTCQB: EPWCF , Forum ) back in February 2020 , the company was pioneering new technologies in the still-emerging medical cannabis and CBD markets. Fast-forward to today and Empower Clinics has pi...
Dave Jackson | December 15, 2021 |

Aytu Bio Shares Skyrocket After Gaining US Distribution Rights for Coronavirus Screening Test

Aytu BioScience shares rose by more than 750% at times today after the company reported that it secured an exclusive U.S. distribution agreement for COVID-19 point-of-care Rapid Test from a Hong Kong firm. Aytu BioScience Inc. (AYTU:NASDAQ) announced today...
Streetwise Reports | March 11, 2020 |

Biopharma Launches Trial Testing Nitric Oxide as COVID-19 Treatment

The design, timeline and takeaways of Beyond Air's study are presented in a ROTH Capital Partners report. In a June 16 research note, ROTH Capital Partners analyst Scott Henry reported that Beyond Air Inc. (XAIR:NASDAQ) enrolled the first patient in its U.S. clin...
Streetwise Reports | June 18, 2020 |

A Market ‘Game Changer’ for Rapid COVID-19 At-Home Testing?

(Click image to play video) While we can finally see light at the end of the tunnel in the fight against COVID-19, the global pandemic has invariably changed how we interact with the world around us. The two big names when it comes to fighting the virus are ...
Dave Jackson | March 23, 2021 |

Buzz on the Bullboards: Big Movers in Mining, Industrials, & Cannabis

(Image via Ivanhoe Mines Ltd.) Is cannabis on the verge of a breakout? Which industrial plays are advancing in the market? What is the next resource mining investors are tracking? Does a spike in a market’s collective share price signify an opportu...
Stockhouse Editorial | February 3, 2021 |

Buzz on the Bullboards: In the COVID Fallout, New Players Emerge

Back in early March 2020, the COVID-19 pandemic was still not much of a concern for the markets. While investors were keeping an eye on it, compared to other geopolitical factors at the time, it was mostly an afterthought of little consequence. Fast-forward a year...
Stockhouse Editorial | March 3, 2021 |

XPhyto: Buyouts, Biosensors and a Booming Business

Test, test, test! It’s the World Health Organization’s battle cry in the global war against COVID-19 and other coronaviruses – including future outbreaks. And it is not getting any less resonant as new variants continue to cause ha...
Marc Davis | August 3, 2021 |

Buzz on the Bullboards: Competition Heats Up in Top Sectors

(Image via HEXO Corp.) It can be hard to keep track of the news cycle, but you can bet the markets are going to be more volatile. That has been the case this autumn trading season so far, and October does not seem to be letting up anytime soon. The Stockhouse Bu...
Stockhouse Editorial | October 6, 2021 |
1 2 3 4 5 6 7 8 9 10 ...